Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Compare UK pharmaceutical companies and biotech shares. See a comparison of key indicators, including pharma stock price targets and analyst recommendations.
Comparison Results
Name | Price | Price Change | Analyst Price Target | Analyst Consensus | Volume | Market Cap | Smart Score | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|
AstraZeneca | 10654.00p | 639p (-5.66%) | 12,750.00p (19.67% Upside) | 9 Buy 3 Hold 0 Sell Strong Buy | 292.97K | £174.67B | premium | ||
GlaxoSmithKline | 1497.20p | 6.315p (-0.42%) | 1,509.38p (0.81% Upside) | 3 Buy 4 Hold 3 Sell Hold | 603.19K | £61.24B | premium | ||
Hikma Pharmaceuticals | 2030.50p | 45.5p (-2.19%) | 2,165.00p (6.62% Upside) | 3 Buy 4 Hold 0 Sell Moderate Buy | 55.49K | £4.56B | premium | ||
HUTCHMED (China) Limited | 299.50p | 5.5p (-1.8%) | 355.88p (18.82% Upside) | 2 Buy 0 Hold 0 Sell Moderate Buy | 132.99K | £2.65B | premium | ||
Dechra Pharmaceuticals | 3796.00p | 0p (0%) | ― | ― | 31.74K | £4.32B | premium |
Performance Comparison
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Pharma & Biotech Stocks Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Pharma & Biotech Stocks
AstraZeneca
premium
premium
Buy
premium
premium
Reiterated
Hikma Pharmaceuticals
premium
premium
Buy
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Hold
premium
premium
Reiterated
HUTCHMED (China) Limited
premium
premium
Buy
premium
premium
Reiterated
Dechra Pharmaceuticals
premium
premium
Hold
premium
premium
Downgraded
AstraZeneca
premium
premium
Buy
premium
premium
Reiterated
AstraZeneca
premium
premium
Buy
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Sell
premium
premium
Reiterated
GlaxoSmithKline
premium
premium
Hold
premium
premium
Reiterated
AstraZeneca
premium
premium
Hold
premium
premium
Reiterated
Most Recent Earnings of Pharma & Biotech Stocks
AstraZeneca
Jul 28, 2023
Jun 01, 2023
141.867
GlaxoSmithKline
Jul 26, 2023
Jun 01, 2023
34.7
Hikma Pharmaceuticals
Aug 03, 2023
Jun 01, 2023
75.15
HUTCHMED (China) Limited
Jul 31, 2023
Jun 01, 2023
-15.571
Dechra Pharmaceuticals
Oct 12, 2023
Jun 01, 2023
16.1
Pharma & Biotech Stocks - FAQ
Which Pharma & Biotech stocks have a "Strong Buy" analyst rating?
These Pharma & Biotech stocks currently have a "Strong Buy" analyst rating consensus:
AstraZeneca - Strong Buy, based on 12 analyst ratings, 9 Buy, 3 Hold, and 0 Sell.
Are Pharma & Biotech stocks overpriced?
AstraZeneca's stock price is currently 10,654.00p, and its average 12-month price target is 12,750.00p.
GlaxoSmithKline's stock price is currently 1,497.20p, and its average 12-month price target is 1,509.38p.
Hikma Pharmaceuticals's stock price is currently 2,030.50p, and its average 12-month price target is 2,165.00p.
HUTCHMED (China) Limited's stock price is currently 299.50p, and its average 12-month price target is 355.88p.
Dechra Pharmaceuticals's stock price is currently 3,796.00p, and its average 12-month price target is N/A.
Which Pharma & Biotech stocks pay dividends?
AstraZeneca does not currently pay dividends.
GlaxoSmithKline does not currently pay dividends.
Hikma Pharmaceuticals does not currently pay dividends.
HUTCHMED (China) Limited does not currently pay dividends.
Dechra Pharmaceuticals does not currently pay dividends.
Popular Stocks Comparisons
Latest News
Pharma & Biotech Stock Events
Stock | Type | Date |
|---|---|---|
GlaxoSmithKline | Earnings Release | Nov 01, 2023 |
AstraZeneca | Earnings Release | Nov 09, 2023 |
GlaxoSmithKline | Earnings Release | Jan 31, 2024 |
AstraZeneca | Earnings Release | Feb 08, 2024 |
Hikma Pharmaceuticals | Earnings Release | Feb 22, 2024 |